ESMO Clinical Practice Guidelines: Endocrine and Neuroendocrine Cancers
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
Latest enhanced and revised set of guidelines
ESMO has two Clinical Practice Guidelines on Neuroendocrine Tumours: Neuroendocrine bronchial and thymic tumours and Neuroendocrine gastroenteropancreatic tumours. They include information on incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.
Endocrine and neuroendocrine tumours
Neuroendocrine Bronchial and Thymic Tumours: ESMO Clinical Practice Guidelines
Published in 2012 – Ann Oncol 2012; 23 (Suppl 7): vii120-vii123
Authors: K. Öberg, P. Hellman, P. Ferolla, M. Papotti
of Neuroendocrine Bronchial and Thymic Tumours: ESMO Clinical Practice Guidelines
Endocrine and neuroendocrine tumours
Neuroendocrine Gastroenteropancreatic Tumours: ESMO Clinical Practice Guidelines
Published in 2012 – Ann Oncol 2012; 23 (Suppl 7): vii124-vii130.
Authors: K. Öberg, U. Knigge, D. Kwekkeboom, A. Perren
Endocrine and neuroendocrine tumours
Adrenal cancer: ESMO Clinical Practice Guidelines
Published in 2012 – Ann Oncol 2012; 23 (Suppl 7): vii131-vii138.
Authors: A. Berruti, E. Baudin, H. Gelderblom, H. R. Haak, F. Porpiglia, M. Fassnacht, G. Pentheroudakis
Endocrine and neuroendocrine tumours
Thyroid cancer: ESMO Clinical Practice Guidelines
Published in 2012 – Ann Oncol 2012; 23 (Suppl 7): vii110-vii119.
Authors: F. Pacini, M. G. Castagna, L. Brilli, G. Pentheroudakis